Biocon Limited
BIOCON
Pozycja w akcjach
#3386
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Cena akcji
$3.75
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$5.13B
Zmiana (1 dzień)
-2.30%
Zmiana (1 rok)
-9.49%
Kraj
IN
Handel Biocon Limited (BIOCON)
Kategoria
Healthcare
Zyski dla Biocon Limited (BIOCON)
Zyski w Jun 2026 TTM: $52.82M
Według najnowszych raportów finansowych Biocon Limited, obecny zysk firmy wynosi $52.82M. W roku 2024 firma osiągnęła zysk w wysokości $182.91M, wzrost w porównaniu do zysku z roku 2023, który wynosił $109.16M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Biocon Limited od 2004 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $52.82M | -76.06% |
| 2025 | $220.59M | 20.60% |
| 2024 | $182.91M | 67.56% |
| 2023 | $109.16M | -15.71% |
| 2022 | $129.51M | -11.21% |
| 2021 | $145.85M | -9.56% |
| 2020 | $161.27M | -7.82% |
| 2019 | $174.96M | 86.74% |
| 2018 | $93.69M | -28.50% |
| 2017 | $131.03M | 15.54% |
| 2016 | $113.40M | 13.38% |
| 2015 | $100.02M | -3.94% |
| 2014 | $104.12M | -7.29% |
| 2013 | $112.30M | 45.09% |
| 2012 | $77.40M | -22.86% |
| 2011 | $100.34M | 28.22% |
| 2010 | $78.26M | 52.81% |
| 2009 | $51.21M | -11.25% |
| 2008 | $57.70M | 18.55% |
| 2007 | $48.67M | 7.03% |
| 2006 | $45.48M | -7.69% |
| 2005 | $49.26M | 32.27% |
| 2004 | $37.24M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| $5.27B | 9,886.99% |
US
|
|
| $-3.09B | -5,944.63% |
US
|
|
| $-4.02B | -7,703.88% |
AU
|
|
| - | - |
CH
|
|
| $1.95B | 3,593.17% |
NL
|
